Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|October 29, 1987
Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importanceJ P Allain, Y Laurian, D A Paul, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 22, 2000
[Which urologic treatment alternatives are there for the hemophiliac patient?]G Benoit, T Lambert, P Blanchet, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|July 1, 1992
[Anti-HCV and recipients: situation in hemophiliacs in 1991]P Maisonneuve, A M Couroucé, F Ferrer le Coeur, et al.
British Journal of Haematology|September 21, 2001
Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophiliaB Guillet, F Kriaa, M G Huysse, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study GroupJ M Lusher, H R Roberts, G Davignon, et al.
British Journal of Haematology|August 1, 1993
Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresisM Tartary, D Vidaud, Y Piao, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Long-term survival of HIV-infected patients with haemophiliaN Stieltjes, Y Sultan, C Rothschild, et al.
Thrombosis and Haemostasis|February 1, 1995
Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrateC Guérois, Y Laurian, C Rothschild, et al.
La Revue De Medecine Interne|July 1, 2008
[Peripheral and bone marrow plasmacytosis in dengue fever: report of a case]T Bibi-Triki, N Aras, T Braun, et al.
British Journal of Haematology|January 1, 1994
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study GroupP M Mannucci, A Gringeri, G Savidge, et al.
Pageof 6